Natural Capsules Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "NATURAL CAPSULES LIMITED REPORTS Q3 & 9MFY26 RESULTS".
NATCAPSUQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natural Capsules Limited reported weak Q3FY26 results with revenue falling 18% quarter-on-quarter and 14% year-on-year to ₹37.75 crore. The company posted a loss of ₹7.12 crore at the PAT level with negative EBITDA margins of 6.16%, while EPS turned negative at ₹(6.88). For the nine months ended December 2025, revenue grew marginally by 4% year-on-year to ₹128.75 crore, but the company reported a cumulative loss of ₹19.69 crore. Management attributed the weakness to a temporary shutdown of the Puducherry unit due to a regulatory action on its manufacturing licence (now resolved) and delayed commercial scale-up of the API fermentation block. On the positive side, US trade tariffs on HPMC capsules have eased, deferred Q3 dispatches from Puducherry are expected to flow into Q4FY26, and partnership discussions to use the fermentation block on a contractual basis are at an advanced stage.
The deeply negative profitability and steep year-on-year declines point to significant near-term pressure on the stock, but with Puducherry back online, US tariff relief in place, and management guiding to a meaningful Q4 improvement, the release frames a turnaround story that investors will be watching closely.